Overview

The EMPOwER Study Evaluating Multiparameter Gene Testing as a Predictor of Short Term Endocrine Therapy Response in Hormone Receptor Positive Breast Cancers

Status:
Unknown status
Trial end date:
2018-08-01
Target enrollment:
Participant gender:
Summary
Evaluating Multiparameter Gene Testing as a Predictor of Short Term Endocrine Therapy Response in Hormone Receptor Positive Breast Cancers
Phase:
Phase 2
Details
Lead Sponsor:
Ottawa Hospital Research Institute
Treatments:
Anastrozole
Hormones
Tamoxifen